DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Pharmacovigilance Software Market By Functionality, By Delivery Mode, By End-Use And Segment Forecasts To 2024" report to their offering.
The global pharmacovigilance (PV) software market was valued at USD 117.3 million in 2015 and is expected to reach a value of USD 207.3 million by 2024. Increasing emphasis on regulatory compliances by government entities such as the U.S. FDA, European Medical Agency, etc. coupled with supportive initiatives are anticipated to drive the PV software market over the forecast period.
Increasing demand for fully integrated systems in an attempt to avert errors in database management is a crucial factor responsible for the adoption of these systems. Moreover, associated benefits of cloud-based platforms, such as remote access to information, reduction of operational costs, and ease of access are factors contributing toward the market growth in the near future.
North America held the largest market share as of 2015, majorly owing to the government aided initiatives favoring the adoption of PV software systems. For instance, the Open FDA initiative provides scientists and application developers the access to its massive database through open search-based programs, which is anticipated to boost the usage rates over the forecast period. Mini-Sentinel is a project started by the U.S. FDA to promote active surveillance systems, which provide statistically relevant data in less time. The aforementioned initiatives strengthen the growth of the regional market
Many healthcare IT companies are shifting toward hosting of cloud-based platforms to gain an edge over the competition.
Companies Mentioned:
- AB cube
- Max Application
- Ennov Solutions, Inc.
- ArisGlobal
- EXTEDO GmbH
- Online Business Applications, Inc.
- Oracle Corporation
- Sparta Systems, Inc.
- United BioSource Corporation
-
Relsys
Key Topics Covered:
1 Research Methodology & Scope
2 Executive Summary
3 Market Snapshot
4 Market Variables, Trends & Scope
5 Market Categorization 1: Functionality Estimates & Trend Analysis
6 Market Categorization 2: Delivery Mode Estimates & Trend Analysis
7 Market Categorization 3: End-use Estimates & Trend Analysis
8 Market Categorization 4: Regional Estimates & Trend Analysis, by Functionality, Delivery Mode, and End-use
9 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/mjqlrq/pharmacovigilance
